Predictors of response to tofacitinib or etanercept in a Phase 3 randomised, non-inferiority study in patients with moderate to severe chronic plaque psoriasis

被引：0

作者：

Lambert, J. ^{[1
]}

Strohal, R. ^{[2
]}

de la Cruz, C. ^{[3
]}

Thaci, D. ^{[4
]}

Bachelez, H. ^{[5
]}

Iversen, L. ^{[6
]}

Rottinghaus, S. ^{[7
]}

Tallman, A. ^{[8
]}

Tan, H. ^{[7
]}

Berstein, G. ^{[9
]}

机构：

[1] Ghent Univ Hosp, Ghent, Belgium

[2] Fed Acad Teaching Hosp Feldkirch, Feldkirch, Austria

[3] Clin Dermacross, Santiago, Chile

[4] Univ Med Sch, Comprehens Ctr Inflammat Med, Schleswig Holstein Campus, Lubeck, Germany

[5] Univ Paris Diderot, Hop St Louis, APHP, Sorbonne Paris Cite, Paris, France

[6] Aarhus Univ Hosp, Aarhus C, Denmark

[7] Pfizer Inc, Groton, CT 06340 USA

[8] Pfizer Inc, New York, NY USA

[9] Pfizer Inc, Cambridge, MA USA

来源：

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2016年 / 30卷

关键词：

etanercept; psoriasis; tofacitinib;

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

P152

引用

页码：78 / 78

页数：1

共 50 条

[41] Two phase 3 studies of oral tofacitinib in patients with moderate to severe plaque psoriasis: 16-week efficacy and safety results
Papp, Kim A.
Menter, Martin A.
Abe, Masatoshi
Elewski, Boni E.
Feldman, Steven R.
Gottlieb, Alice G.
Thaci, Diamant
Luger, Thomas
Tatulych, Svitlana
Gupta, Pankaj
Proulx, James
Lan, Shu-Ping
Wolk, Robert
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB66 - AB66
[42] ABT-874 versus etanercept and placebo in patients with moderate to severe chronic plaque psoriasis: Efficacy and safety results
Strober, Bruce
Crowley, Jeffrey
Valdes, Joaquin
Gu, Yihua
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : AB155 - AB155
[43] ABT-874 versus etanercept and placebo in patients with moderate to severe chronic plaque psoriasis: efficacy and safety results
Strober, B.
Crowley, J.
Yamauchi, P.
Yoo, S.
Gu, Y.
Valdes, J.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2010, 24 : 10 - 11
[44] Efficacy and safety results of ABT-874 versus etanercept and placebo in patients with moderate to severe chronic plaque psoriasis
Gottlieb, Alice
Leonardi, Craig
Valdes, Joaquin
Gu, Yihua
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : AB159 - AB159
[45] Open-label study of etanercept treatment in patients with moderate-to-severe plaque psoriasis who lost a satisfactory response to adalimumab
Bagel, J.
Tyring, S.
Rice, K. C.
Collier, D. H.
Kricorian, G.
Chung, J.
Iles, J.
Stolshek, B. S.
Kaliyaperumal, A.
Papp, K. A.
BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (02) : 411 - 418
[46] Comparison of ustekinumab (UST) and etanercept (ETA) in the treatment of moderate to severe plaque-psoriasis: a multicentric, random phase 3-study
Luger, T. A.
Griffiths, C.
Strober, B.
Van de Kerkhof, P. C.
Ho, V
Guzzo, C.
Yeilding, N.
Fidelus-Gort, R.
Zhou, B.
Xia, K.
Menter, A.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2009, 7 : 205 - 206
[47] Efficacy of tofacitinib for the treatment of nail psoriasis: Two 52-week, randomized, controlled phase 3 studies in patients with moderate-to-severe plaque psoriasis
Merola, Joseph F.
Elewski, Boni
Tatulych, Svitlana
Lan, Shuping
Tallman, Anna
Kaur, Mandeep
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 77 (01) : 79 - +
[48] Clinical factors predicting the therapeutic response to ustekinumab in patients with moderate to severe chronic plaque psoriasis
Hwang, Young Ji
Youn, Sang Woong
Kim, Bo Ri
Yu, Dae Young
Kim, Youngdoe
Pires, Antonio
Cho, Soyun
Seo, Seong Jun
Lee, Eun So
Roh, Joo Young
Choi, Gwang Seong
Lee, Min Geol
JOURNAL OF DERMATOLOGY, 2017, 44 (05): : 560 - 566
[49] A randomized study to evaluate the efficacy and safety of adding topical therapy to etanercept in patients with moderate to severe plaque psoriasis
Lebwohl, Mark G.
Kircik, Leon
Duffin, Kristina Callis
Pariser, David
Hooper, Michele
Wenkert, Deborah
Thompson, Elizabeth H. Z.
Yang, Jun
Kricorian, Greg
Koo, John
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 69 (03) : 385 - 392
[50] Mild Cognitive Impairment in Patients with Moderate to Severe Chronic Plaque Psoriasis
Gisondi, Paolo
Sala, Francesca
Alessandrini, Franco
Avesani, Virginia
Zoccatelli, Giada
Beltramello, Alberto
Moretto, Giuseppe
Gambina, Giuseppe
Girolomoni, Giampiero
DERMATOLOGY, 2014, 228 (01) : 78 - 85

← 1 2 3 4 5 →